UniProtKB/Swiss-Prot Q9BXB1: Variant p.Asp844Gly

Leucine-rich repeat-containing G-protein coupled receptor 4
Gene: LGR4
Feedback?

Variant information Variant position:

844 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Aspartate (D) to Glycine (G) at position 844 (D844G, p.Asp844Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and acidic (D) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

In DPSL; uncertain significance; when transfected in HEK293T cells has no effect on WNT signaling; decreased protein expression in transfected cells. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs34804482 [ dbSNP | Ensembl ]

Sequence information Variant position:

844 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

951 The length of the canonical sequence.
Location on the sequence:

GSVSVSISSQGGCLEQDFYY D CGMYSHLQGNLTVCDCCESF The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         GSVSVSISSQGGCLE---------QDFYYDCGMYSHLQG-NLTVCDCCESF

Mouse                         GSVSVSISSQGGCGE---------QDFYYDCGMYSHLQG-N

Rat                           GSVSVSISSQGGCGE---------QDFYYDCGMYSHLQG-N

Bovine                        GSASVSISSQAGCVE---------QDFYYDCGMYSHLQG-N

Xenopus tropicalis            GSVAVATNSQRGCVT---------QDFYYDFGMYSHLQGGN

Zebrafish                     CGRLVAKTVTKGTVAGGSPVSDDGEGLSSDCGMYTKLHGDS

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	25 – 951	Leucine-rich repeat-containing G-protein coupled receptor 4
Topological domain	805 – 951	Cytoplasmic

Literature citations
LGR4 deficiency results in delayed puberty through impaired Wnt/beta-catenin signaling.
Mancini A.; Howard S.R.; Marelli F.; Cabrera C.P.; Barnes M.R.; Sternberg M.J.; Leprovots M.; Hadjidemetriou I.; Monti E.; David A.; Wehkalampi K.; Oleari R.; Lettieri A.; Vezzoli V.; Vassart G.; Cariboni A.; Bonomi M.; Garcia M.I.; Guasti L.; Dunkel L.;
JCI Insight 5:0-0(2020)
Cited for: VARIANTS DPSL VAL-96; CYS-363 AND GLY-844; INVOLVEMENT IN DPSL; CHARACTERIZATION OF VARIANTS DPSL VAL-96; CYS-363 AND GLY-844;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.